CCM
LMAT icon

Copeland Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Copeland Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.1M Sell
870,692
-18,285
-2% -$1.74M 2.11% 3
2025
Q4 		$72.1M Sell
888,977
-51,351
-5% -$4.42M 1.61% 11
2025
Q3 		$82.3M Sell
940,328
-49,709
-5% -$4.44M 1.71% 5
2025
Q2 		$82.2M Sell
990,037
-88,686
-8% -$7.41M 1.69% 6
2025
Q1 		$90.5M Sell
1,078,723
-93,292
-8% -$8.68M 1.81% 7
2024
Q4 		$108M Buy
1,172,015
+8,623
+0.7% +$829K 2.01% 4
2024
Q3 		$108M Buy
1,163,392
+11,318
+1% +$981K 1.88% 4
2024
Q2 		$94.8M Sell
1,152,074
-138,819
-11% -$10.2M 1.77% 8
2024
Q1 		$85.7M Buy
1,290,893
+30,932
+2% +$1.91M 1.56% 13
2023
Q4 		$71.5M Buy
1,259,961
+28,720
+2% +$1.5M 1.43% 20
2023
Q3 		$67.1M Buy
1,231,241
+5,515
+0.4% +$327K 1.44% 22
2023
Q2 		$82.5M Sell
1,225,726
-139,016
-10% -$8.48M 1.7% 7
2023
Q1 		$70.2M Buy
1,364,742
+87,264
+7% +$4.24M 1.65% 12
2022
Q4 		$58.8M Buy
1,277,478
+53,896
+4% +$2.52M 1.55% 16
2022
Q3 		$62M Buy
1,223,582
+11,276
+0.9% +$563K 2.05% 4
2022
Q2 		$55.2M Sell
1,212,306
-2,699
-0.2% -$121K 1.75% 8
2022
Q1 		$56.5M Buy
1,215,005
+9,806
+0.8% +$439K 1.56% 13
2021
Q4 		$60.5M Buy
1,205,199
+80,112
+7% +$4.14M 1.57% 13
2021
Q3 		$59.7M Buy
1,125,087
+62,054
+6% +$3.5M 1.7% 5
2021
Q2 		$64.9M Buy
1,063,033
+171,708
+19% +$9.12M 1.95% 5
2021
Q1 		$43.5M Sell
891,325
-60,170
-6% -$2.82M 1.35% 36
2020
Q4 		$38.5M Buy
951,495
+63,577
+7% +$2.27M 1.52% 25
2020
Q3 		$28.9M Buy
887,918
+221,953
+33% +$6.66M 1.28% 38
2020
Q2 		$17.6M Buy
665,965
+24,917
+4% +$651K 0.91% 48
2020
Q1 		$16M Buy
641,048
+79,975
+14% +$2.47M 0.97% 43
2019
Q4 		$20.2M Buy
561,073
+20,588
+4% +$710K 0.88% 47
2019
Q3 		$18.5M Buy
540,485
+152,753
+39% +$4.88M 0.95% 42
2019
Q2 		$10.8M Buy
387,732
+209,913
+118% +$5.83M 0.6% 59
2019
Q1 		$5.51M Buy
177,819
+177,086
+24,159% +$4.73M 0.35% 77
2018
Q4 		$17K Buy
+733
New +$20K ﹤0.01% 163

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Copeland Capital Management's LMAT Position: Q1 2026 in Review

Copeland Capital Management reduced its LeMaitre Vascular (LMAT) stake by 2.1% in Q1 2026, selling an estimated $1.74M and leaving 870,692 shares worth $95.1M. The position accounts for 2.11% of the portfolio, ranked #3.

Copeland Capital Management first reported a position in LMAT in Q4 2018 and has held it in 30 quarters since. The position peaked at $108M in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Copeland Capital Management held 870,692 shares of LeMaitre Vascular worth $95.1M as of Q1 2026.
  • Copeland Capital Management sold 18,285 LeMaitre Vascular shares in Q1 2026, an estimated $1.74M.
  • LeMaitre Vascular made up 2.11% of Copeland Capital Management's portfolio in Q1 2026, its #3 holding.
  • Copeland Capital Management first reported a position in LeMaitre Vascular in Q4 2018 and has held it in 30 quarters since.
  • Copeland Capital Management's LeMaitre Vascular position peaked at $108M in Q3 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Copeland Capital Management's 13F filing for Q1 2026, filed 6 May 2026.